Hongbiao Mo

Papers

Total Citations

H-Index

About

Hongbiao Mo is a leading surgical oncologist whose research focuses on advancing minimally invasive and robotic-assisted techniques for the treatment of thyroid and breast cancers. His work is particularly noted for pioneering the use of robot-assisted surgery to access anatomically challenging regions, such as the internal mammary lymph chain for breast cancer staging, a procedure detailed in his 2017 paper (9 citations). Mo’s most impactful contribution is a landmark 2023 systematic review and Bayesian network meta-analysis comparing total thyroidectomy methods for differentiated thyroid cancer (17 citations). This study provides a comprehensive, evidence-based evaluation of surgical integrity, safety, and postoperative outcomes across emerging remote-access techniques, guiding clinical decision-making. By synthesizing data from multiple databases, Mo has helped establish clearer benchmarks for surgical efficacy and patient experience. His research directly addresses the critical need for accurate staging and less invasive options, demonstrating a commitment to improving both oncological outcomes and quality of life. With a growing citation record, Hongbiao Mo is recognized as an innovator in surgical oncology, shaping the future of endocrine and breast cancer surgery.